See what you could lose
Based on clinical trial averages for dual GLP-1/GIP agonist treatment
Estimates based on 5%, 15%, 20%, and 22.5% average body weight loss at each milestone. Individual results vary.
Thousands of patients and counting
Individual results vary. All patients completed at least 12 weeks of treatment. Names changed for privacy.
to a friend
"Within 3 weeks, the constant food noise in my head just... stopped. I finally feel like I have control. I went from size 14 to size 8."
"Six months later, all my labs are normal. I'm off my blood pressure medication completely. This literally saved my life."
"The weekly injection is nothing - I barely feel it. My energy is back, my clothes fit, and my confidence has returned."
"I avoided diabetes. A1C is 5.4, blood pressure is normal. 48 pounds gone. That's worth more than any number on a scale."
"I'm down 28 pounds and actually look toned. My trainer noticed before I told him. That's when I knew this was different."
"40 pounds down. I finally feel like myself again. My energy is back, my joints don't hurt, and I actually look forward to getting dressed."
Patients may have been compensated. Results not independently verified. Individual results will vary. Treatment includes medication, reduced-calorie diet, and exercise.
Want results like these? No insurance needed takes 5 minutes.
Start my screening →Typical weight loss over 12 months
Based on clinical trial data for dual GLP-1/GIP receptor agonist treatment
Results from dual GLP-1/GIP receptor agonist clinical trials. Individual results vary. Chart shows average trajectory for patients completing 72 weeks of treatment.
What to expect at each stage
Month 1-3
Starting dose phase. Body adjusts to medication, appetite reduces, initial weight loss begins.
Month 3-6
Full therapeutic dose. Accelerated weight loss, significant visible changes, lab improvements.
Month 6-12
Peak results. Approaching target weight, maintenance planning begins, sustained health improvements.
Based on clinical trial data and our patient population averages. Individual results vary based on starting weight, adherence, and lifestyle factors.
Health improvements our patients report
87% report improved energy
Patients consistently report feeling more energetic, sleeping better, and having improved stamina for daily activities and exercise.
73% reduce or stop other medications
Blood pressure medications, cholesterol medications, and diabetes medications reduced or eliminated under physician supervision.
91% report improved confidence
Beyond physical changes, patients describe renewed self-confidence, improved social engagement, and better mental health outcomes.
Backed by landmark clinical trials
Tirzepatide vs. placebo
2,539 participants over 72 weeks. Patients on the highest dose lost an average of 22.5% of body weight vs. 2.4% for placebo.
Semaglutide 2.4mg vs. placebo
1,961 participants over 68 weeks. Patients lost an average of 14.9% of body weight, with 86% losing at least 5%.
Published in The New England Journal of Medicine. Results achieved with medication, reduced-calorie diet, and increased physical activity.
Your results could be next
Join 15,000+ patients who stopped guessing and started seeing real, lasting change.